Subscribe
shutterstock_761246722_casimiro_pt
Casimiro PT / Shutterstock.com
6 October 2020BiotechnologyMuireann Bolger

Regeneron sued over antibody protein used to treat Trump’s COVID-19 symptoms

Regeneron Pharmaceuticals is facing claims that its “antibody cocktail”, which was administered to  President Donald Trump to treat his COVID-19 symptoms, was developed with the unauthorised use of a fluorescent protein.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
English court resumes Amgen cholesterol patent suit
23 October 2020   The English High Court has lifted a stay on Amgen’s lawsuit which accused Sanofi-Aventis and Regeneron of infringing a patent covering pharmaceuticals which treat elevated cholesterol levels.
Americas
Kilpatrick Townsend hires litigation team from DLA Piper
19 October 2020   Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper.
Americas
Alnylam and Regeneron unveil RNAi partnership
9 April 2019   Pharmaceutical companies Alnylam and Regeneron will collaborate on the development and commercialisation of RNA interference therapeutics.


Editor's picks

Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant
Americas
Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant
3 April 2025

Editor's picks

Americas
Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant
3 April 2025
Americas
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025
Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025
Americas
LSPN finalists revealed for first-ever US awards
3 March 2025

More on this story

Big Pharma
English court resumes Amgen cholesterol patent suit
23 October 2020   The English High Court has lifted a stay on Amgen’s lawsuit which accused Sanofi-Aventis and Regeneron of infringing a patent covering pharmaceuticals which treat elevated cholesterol levels.
Americas
Kilpatrick Townsend hires litigation team from DLA Piper
19 October 2020   Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper.
Americas
Alnylam and Regeneron unveil RNAi partnership
9 April 2019   Pharmaceutical companies Alnylam and Regeneron will collaborate on the development and commercialisation of RNA interference therapeutics.

More on this story

Big Pharma
English court resumes Amgen cholesterol patent suit
23 October 2020   The English High Court has lifted a stay on Amgen’s lawsuit which accused Sanofi-Aventis and Regeneron of infringing a patent covering pharmaceuticals which treat elevated cholesterol levels.
Americas
Kilpatrick Townsend hires litigation team from DLA Piper
19 October 2020   Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper.
Americas
Alnylam and Regeneron unveil RNAi partnership
9 April 2019   Pharmaceutical companies Alnylam and Regeneron will collaborate on the development and commercialisation of RNA interference therapeutics.

More features

EPO: Biotech innovation strong, while pharma trails behind
LSPN chair: Uncertainty lies ahead for life sciences
UPC issues sweeping injunction against Meril in heart valve case
PierFerd taps pharma and biotech patent expert from Weiss & Arons
Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant
Mental health IP toolkit: Diversity Champ’s stress-busting tips
Eli Lilly piles on weight loss drug suits to ward off revenue squeeze
Patent cliff: 5 blockbusters running out of road